These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31830442)

  • 41. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
    Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
    Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
    J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific Deubiquitinating Enzymes Promote Host Restriction Factors Against HIV/SIV Viruses.
    Gao W; Rui Y; Li G; Zhai C; Su J; Liu H; Zheng W; Zheng B; Zhang W; Yang Y; Hua S; Yu X
    Front Immunol; 2021; 12():740713. PubMed ID: 34630422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
    Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
    Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s.
    Hu Y; Knecht KM; Shen Q; Xiong Y
    FEBS J; 2021 Jun; 288(11):3407-3417. PubMed ID: 32893454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.
    Nchioua R; Kmiec D; Gaba A; Stürzel CM; Follack T; Patrick S; Kirmaier A; Johnson WE; Hahn BH; Chelico L; Kirchhoff F
    J Virol; 2021 Aug; 95(17):e0080821. PubMed ID: 34132575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
    Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
    Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.
    Champiat S; Garrison KE; Raposo RA; Burwitz BJ; Reed J; Tandon R; York VA; Newman LP; Nimityongskul FA; Wilson NA; Almeida RR; Martin JN; Deeks SG; Rosenberg MG; Wiznia AA; Spotts GE; Pilcher CD; Hecht FM; Ostrowski MA; Sacha JB; Nixon DF
    J Virol; 2013 Jun; 87(11):6073-80. PubMed ID: 23536679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
    Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors.
    Binning JM; Smith AM; Hultquist JF; Craik CS; Caretta Cartozo N; Campbell MG; Burton L; La Greca F; McGregor MJ; Ta HM; Bartholomeeusen K; Peterlin BM; Krogan NJ; Sevillano N; Cheng Y; Gross JD
    PLoS Pathog; 2018 Jan; 14(1):e1006830. PubMed ID: 29304101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
    Takeuchi H; Buckler-White A; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Kao S; Sokolskaja E; Pertel T; Luban J; Strebel K
    J Virol; 2007 Aug; 81(15):8080-90. PubMed ID: 17522232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
    Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
    J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
    Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
    Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif.
    Niewiadomska AM; Yu XF
    Curr Top Microbiol Immunol; 2009; 339():1-25. PubMed ID: 20012521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
    Sawyer SL; Emerman M; Malik HS
    PLoS Biol; 2004 Sep; 2(9):E275. PubMed ID: 15269786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid evolution of primate antiviral enzyme APOBEC3G.
    Zhang J; Webb DM
    Hum Mol Genet; 2004 Aug; 13(16):1785-91. PubMed ID: 15198990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host.
    Krupp A; McCarthy KR; Ooms M; Letko M; Morgan JS; Simon V; Johnson WE
    PLoS Pathog; 2013; 9(10):e1003641. PubMed ID: 24098115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.
    Azimi FC; Lee JE
    Protein Sci; 2020 Feb; 29(2):391-406. PubMed ID: 31518043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).
    Schröfelbauer B; Chen D; Landau NR
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3927-32. PubMed ID: 14978281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.
    Zheng W; Ling L; Li Z; Wang H; Rui Y; Gao W; Wang S; Su X; Wei W; Yu XF
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.